National Bank Financial upgraded shares of Extendicare (TSE:EXE – Free Report) to a strong-buy rating in a research report report published on Wednesday morning,Zacks.com reports.
A number of other equities research analysts have also recently issued reports on EXE. BMO Capital Markets lifted their price target on shares of Extendicare from C$13.50 to C$14.50 in a research note on Monday, May 12th. National Bankshares set a C$15.40 target price on shares of Extendicare and gave the company an “outperform” rating in a research report on Thursday. Finally, TD Securities upped their price target on shares of Extendicare from C$13.00 to C$15.00 and gave the stock a “hold” rating in a research report on Thursday, May 22nd. Three investment analysts have rated the stock with a hold rating, one has given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, Extendicare currently has an average rating of “Moderate Buy” and an average target price of C$13.98.
Read Our Latest Stock Report on EXE
Extendicare Stock Performance
Extendicare Dividend Announcement
The company also recently disclosed a jul 25 dividend, which will be paid on Friday, August 15th. Investors of record on Friday, August 15th will be paid a $0.042 dividend. This represents a yield of 3.81%. The ex-dividend date is Thursday, July 31st. Extendicare’s dividend payout ratio is currently 61.20%.
About Extendicare
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Further Reading
- Five stocks we like better than Extendicare
- Insider Buying Explained: What Investors Need to Know
- Why Pure Storage Is a Core Investment for the AI Era
- What Makes a Stock a Good Dividend Stock?
- 2025: A Pivotal Year for Smart Glasses As Meta Invests in Ray-Ban
- How to Invest in Blue Chip Stocks
- Unity’s New Ad Solutions Drive Stock to 52-Week High
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.